ProteomTech Inc., founded in 2001, is rapidly emerging as a product-driven pharmaceutical research and development company. By utilizing their patented protein refolding technology, Pt-Fold TM, ProteomTech has developed a pipeline of three protein drug candidates that are vascular endothelial cell growth inhibitor, recombinant prourokinase and recombinant human thrombin. They provide human proteins for medical research, drug development and for therapeutics and services by optimizing challenging proteins.